Ramachandran S Vasan Selected Research

Cerebrovascular Trauma

10/2020	Growth Differentiation Factor 15 and NT-proBNP as Blood-Based Markers of Vascular Brain Injury and Dementia.
2/2016	Association of Exhaled Carbon Monoxide With Stroke Incidence and Subclinical Vascular Brain Injury: Framingham Heart Study.
9/2015	Associations of Circulating Growth Differentiation Factor-15 and ST2 Concentrations With Subclinical Vascular Brain Injury and Incident Stroke.
10/2013	Serum brain-derived neurotrophic factor and vascular endothelial growth factor levels are associated with risk of stroke and vascular brain injury: Framingham Study.
5/2012	Multiple biomarkers and risk of clinical and subclinical vascular brain injury: the Framingham Offspring Study.
9/2009	Association of plasma ADMA levels with MRI markers of vascular brain injury: Framingham offspring study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ramachandran S Vasan Research Topics

Disease

130	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2002
80	Hypertension (High Blood Pressure) 01/2022 - 02/2002
64	Heart Failure 01/2022 - 08/2002
51	Inflammation (Inflammations) 07/2022 - 07/2004
37	Insulin Resistance 01/2022 - 01/2003
34	Stroke (Strokes) 07/2022 - 08/2003
33	Diabetes Mellitus 01/2020 - 05/2006
32	Myocardial Infarction 01/2022 - 01/2003
29	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 12/2004
27	Atherosclerosis 07/2022 - 08/2005
27	Obesity 03/2022 - 03/2003
25	Atrial Fibrillation 01/2020 - 12/2003
22	Coronary Disease (Coronary Heart Disease) 01/2022 - 03/2003
22	Dementia (Dementias) 01/2022 - 07/2008
17	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 07/2008
17	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2006
15	Chronic Renal Insufficiency 01/2022 - 05/2007
12	Neoplasms (Cancer) 03/2022 - 01/2007
11	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2022 - 09/2002
10	Fibrosis (Cirrhosis) 07/2022 - 05/2004
10	Dyslipidemias (Dyslipidemia) 01/2021 - 07/2007
10	Ventricular Remodeling 12/2019 - 03/2003
9	Ischemic Stroke 01/2022 - 08/2003
8	Albuminuria 09/2021 - 03/2007
7	Chronic Kidney Failure (Chronic Renal Failure) 07/2022 - 05/2009
7	Hypertrophy 01/2022 - 09/2004
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 10/2004
7	Overweight 03/2017 - 08/2006
6	Apnea 11/2022 - 10/2006
6	Renal Insufficiency (Renal Failure) 10/2022 - 12/2003
6	Cerebrovascular Trauma 10/2020 - 09/2009
5	Kidney Diseases (Kidney Disease) 10/2022 - 09/2013
5	Proteinuria 01/2019 - 01/2005
5	Hyperemia 10/2018 - 12/2004
5	Vascular Remodeling 04/2015 - 04/2009
5	Left Ventricular Dysfunction 11/2014 - 08/2002

Drug/Important Bio-Agent (IBA)

97	Biomarkers (Surrogate Marker)IBA 07/2022 - 03/2005
45	HDL CholesterolIBA 01/2022 - 03/2003
37	C-Reactive ProteinIBA 03/2022 - 03/2003
34	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 02/2002
31	LipidsIBA 01/2022 - 12/2004
29	CholesterolIBA 01/2022 - 12/2004
26	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2003
25	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2020 - 09/2002
24	Biological ProductsIBA 01/2022 - 02/2006
24	Triglycerides (Triacylglycerol)IBA 01/2019 - 12/2004
22	CreatinineIBA 09/2021 - 03/2003
20	Proteins (Proteins, Gene)FDA Link 07/2022 - 06/2006
20	Natriuretic PeptidesIBA 03/2021 - 08/2002
16	oxidized low density lipoproteinIBA 12/2020 - 01/2006
16	AldosteroneIBA 10/2013 - 05/2004
15	CalciumIBA 01/2022 - 02/2004
15	HomocysteineIBA 01/2018 - 03/2003
14	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2022 - 12/2004
14	Insulin (Novolin)FDA Link 01/2022 - 12/2004
14	LDL CholesterolIBA 01/2021 - 01/2006
14	Interleukin-6 (Interleukin 6)IBA 02/2015 - 03/2003
13	AlbuminsIBA 09/2021 - 03/2005
13	ReninIBA 09/2013 - 02/2006
12	AdipokinesIBA 01/2021 - 03/2009
11	Fibrinogen (Factor I)FDA Link 01/2018 - 03/2007
10	HDL LipoproteinsIBA 01/2022 - 02/2008
10	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2015 - 07/2004
8	Apolipoproteins E (ApoE)IBA 01/2022 - 05/2014
8	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022 - 10/2003
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 05/2009
8	ApolipoproteinsIBA 11/2018 - 08/2007
8	AdiponectinIBA 02/2016 - 03/2009
8	Hormones (Hormone)IBA 09/2013 - 06/2010
7	Peptides (Polypeptides)IBA 01/2022 - 02/2004
7	Lipoproteins (Lipoprotein)IBA 12/2020 - 03/2005
7	Plasminogen Activator Inhibitor 1IBA 01/2018 - 02/2006
7	LeptinIBA 01/2018 - 04/2009
7	Testosterone (Sustanon)FDA Link 01/2015 - 08/2006
7	SodiumIBA 09/2013 - 02/2004
6	Insulin-Like PeptidesIBA 01/2022 - 01/2016
6	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 05/2010
6	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2021 - 03/2009
6	Lipoprotein(a)IBA 01/2021 - 12/2016
6	Oxyhemoglobins (Oxyhemoglobin)IBA 01/2021 - 10/2006
6	CeramidesIBA 11/2020 - 01/2018
6	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019 - 10/2013
6	Estradiol (Delestrogen)FDA LinkGeneric 08/2017 - 08/2006
6	P-SelectinIBA 02/2015 - 04/2006
6	OsteoprotegerinIBA 02/2015 - 06/2008
6	Gonadal Steroid Hormones (Sex Hormones)IBA 04/2014 - 08/2006
5	Arginine (L-Arginine)FDA Link 11/2020 - 03/2009
5	Growth Differentiation Factor 15IBA 10/2020 - 12/2010
5	Blood Glucose (Blood Sugar)IBA 10/2020 - 03/2003
5	Fatty Acid-Binding ProteinsIBA 01/2018 - 05/2005
5	LDL Lipoproteins (beta Lipoproteins)IBA 01/2018 - 01/2006
5	Vasodilator Agents (Vasodilators)IBA 05/2017 - 12/2004
5	CD40 Ligand (CD40L)IBA 02/2015 - 01/2008
5	ResistinIBA 09/2012 - 03/2009
5	Tissue Inhibitor of Metalloproteinase-1IBA 01/2011 - 09/2004
5	Atrial Natriuretic Factor (ANF)IBA 12/2010 - 02/2004
4	Hemoglobins (Hemoglobin)IBA 01/2022 - 05/2007

Therapy/Procedure

25	Therapeutics 10/2022 - 10/2004
9	Precision Medicine 11/2022 - 10/2020
9	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2019 - 05/2005